NASDAQ:ACB Aurora Cannabis (ACB) Stock Price, News & Analysis $5.06 -0.06 (-1.08%) As of 03:24 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Aurora Cannabis Stock (NASDAQ:ACB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aurora Cannabis alerts:Sign Up Key Stats Today's Range$5.05▼$5.1050-Day Range$3.73▼$5.2452-Week Range$2.56▼$6.36Volume503,027 shsAverage Volume1.18 million shsMarket Capitalization$332.23 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Aurora Cannabis Inc. is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2013, the company develops, produces, distributes and sells cannabis and cannabis-derived products for medical and adult-use markets. Its shares trade on the Toronto Stock Exchange and the Nasdaq under the symbol ACB. Aurora’s product portfolio includes dried cannabis flower, pre-rolls, cannabis oils, softgels, vapes and other cannabis extracts. The company markets products through brands such as Aurora, San Rafael ’71, Daily Special and CanniMed, with offerings varying by market and applicable regulations. The company serves Canada’s regulated adult-use and medical cannabis markets and has expanded its medical cannabis business internationally. Aurora has supplied medical cannabis in selected markets across Europe, Australia and South America, subject to local licensing and regulations. Miguel Martin has served as Aurora Cannabis’ chief executive officer since 2021.AI Generated. May Contain Errors. Read More Aurora Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks10th Percentile Overall ScoreACB MarketRank™: 0.519096994355 of 5 starsAurora Cannabis scored higher than 10% of companies evaluated by MarketBeat, and ranked 851st out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingReduce Consensus RatingAurora Cannabis has received a consensus rating of Reduce. The company's average rating score is 1.80, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 2 sell ratings.Amount of Analyst CoverageAurora Cannabis has only been the subject of 3 research reports in the past 90 days.Read more about Aurora Cannabis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -5.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -5.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aurora Cannabis' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.81% of the float of Aurora Cannabis has been sold short.Short Interest Ratio / Days to CoverAurora Cannabis has a short interest ratio ("days to cover") of 12.75, which indicates bearish sentiment.Change versus previous monthShort interest in Aurora Cannabis has recently increased by 2.72%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.40 News SentimentAurora Cannabis has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Aurora Cannabis this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows12 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is an increase of 140% compared to the previous 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have not sold or bought any company stock.Percentage Held by Insiders0.01% of the stock of Aurora Cannabis is held by insiders.Percentage Held by Institutions47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Aurora Cannabis' insider trading history. Receive ACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACB Stock News HeadlinesCuraleaf Receives All Required Competition Law Clearances for Proposed Acquisition of Aurora CannabisNovember 10 at 8:44 AM | finance.yahoo.comCuraleaf Secures Competition Clearances for Its Hostile Offer for Aurora CannabisNovember 10 at 8:44 AM | finance.yahoo.comThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.November 11 at 1:00 AM | Porter & Company (Ad)Aurora Cannabis Announces Special Meeting and November 18 Record DateNovember 9 at 6:31 PM | tipranks.comThe Big Winner From the Aurora Cannabis-Organigram Deal: CuraleafNovember 9 at 1:50 PM | fool.comAurora Cannabis : Financial StatementsPDF (FS 202690 Q2 2027 Final)November 5, 2026 | marketscreener.comMMarketBeat Week in Review – 10/19 - 10/23 (ACB)A market sell-off spread beyond tech as oil prices surged and AI concerns grew. MarketBeat analysts recap the week's top stories on earnings, from Halliburton to Meta Platforms and General Motors.October 24, 2026 | marketbeat.comAurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over (ACB)Curaleaf raised its hostile bid for Aurora Cannabis to about $5 per share, citing a 217% ex-cash premium, as the two cannabis firms clash over board access and valuation.October 20, 2026 | marketbeat.comSee More Headlines ACB Stock Analysis - Frequently Asked Questions How have ACB shares performed this year? Aurora Cannabis' stock was trading at $4.22 at the beginning of 2026. Since then, ACB shares have increased by 20.5% and is now trading at $5.0850. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc. (NASDAQ:ACB) posted its earnings results on Wednesday, August, 5th. The company reported $0.04 earnings per share for the quarter, beating analysts' consensus estimates of ($0.13) by $0.17. The firm earned $47.62 million during the quarter, compared to analyst estimates of $47.45 million. Aurora Cannabis had a negative net margin of 23.70% and a positive trailing twelve-month return on equity of 3.72%. Read the conference call transcript. When did Aurora Cannabis' stock split? Aurora Cannabis shares reverse split on the morning of Tuesday, February 20th 2024.The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Does Aurora Cannabis have any subsidiaries? Aurora Cannabis subsidiaries include Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and more. Who are Aurora Cannabis' major shareholders? Top institutional investors of Aurora Cannabis include JW Asset Management LLC (0.06%), Silver Oak Securities Incorporated (0.05%) and State of Wyoming (0.04%). How do I buy shares of Aurora Cannabis? Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), Tilray Brands (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA) and NIO (NIO). Company Calendar Last Earnings8/05/2026Today11/11/2026Next Earnings (Estimated)11/12/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ACB's financial health is in the Green zone, according to TradeSmith. ACB has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ACB Previous SymbolNYSE:ACB CIK1683541 Webauroramj.com Phone(604) 362-5207FaxN/AEmployees1,028Year Founded2006Profitability EPS (Trailing Twelve Months)($0.98) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$88.13 million Net Margins-23.70% Pretax Margin-3.81% Return on Equity3.72% Return on Assets3.03% Debt Debt-to-Equity Ratio0.03 Current Ratio5.00 Quick Ratio2.60 Sales & Book Value Annual Sales$321.28 million Price / Sales1.04 Cash Flow$0.69 per share Price / Cash Flow7.35 Book Value$5.64 per share Price / Book0.90Miscellaneous Outstanding Shares65,724,000Free Float65,717,000Market Cap$332.89 million OptionableOptionable Beta0.65 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:ACB) was last updated on 11/11/2026 by MarketBeat.com Staff. From Our PartnersTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredThe Withdrawal You'll Never See on Your StatementA proposal circulating in Washington, dubbed the Mar-a-Lago Accord, calls for tariffs and currency pressure to...Bishop Gold Group | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
